伊伐布雷定在扩张性心肌病慢性心衰患者的治疗效果分析.pdfVIP

lœゥ㠲♁㐉㥝㨗Τ㠲゜

㓇c㩝

çêょ㧦『Ⅵ㏑ゾヴミ㞩㚇ㄤヴミ㢄ㄌ㞖㚢㖊㙸㑳㓳�㓮

㕼㧟㙌;�ž;㓣㒀㓦;㓛▏,

l㕋㕴Àミヶ�㧐㩜㗒�㕋㕴



㕋㕴ゆš㢑�㝧��㧐㩜㗒�㕋㕴



㑡㢒㩝㚳㚢㑆㢥çêょ㧦『㞡�㔇�㠲㘩㖊㙸㏑ゾ∞ミ㞩㚇ミ�㢄㜝ㄌ㞖㚢㑳㓳Μ〇�ヴt㒋㖐㤷㐦.,-5゜/㓇).,.,゜-.�

㓇㓍㦵㕋㕴Àミヶ�㧐㜣�㓡á㚢㏑ゾ∞ミ㞩㚇ㄤヴミ�㢄㜝ㄌ㞖��l㔑㐿ㄌ㞖㚢㚇ㄑ㝪¶ゐ㢗㚢ミ㢄㠲㘩㖊㙸㩜ゝⅥ

㕉∫㛙†⊙�çêょ㧦『㩜ん㨊

™㓇㢲ヰ㖊㙸㑳㓳t㝧㓳

™㓇㖊㙸�㩜ㄌ㞖㚢ミ㘷㤑㖊㙸�㧍ÿµ㩚-,*3/x-2*45%㕀

�㩚㆞,*�,,,-�s㑮㝼�㤑㖊㙸�⊙�µ㩚

e

ggCa�$ざ8,*�,.%

㞗㟵ゾ�㒑㒟㒨��㩚㆞9,*�.-0%㩜ぽミ〜ぉ

㡺�㑼�㨶µ

,*�,,,-�㩜ぽミ〜㟵ゾ㓐ヒΜ㑮㝼㓐ヒ↑㕜㖊㙸�㝼き/hoht㝧㢭çêょ㧦『㞡�N㧆㗝�

�ぜ�

Μ$(�Ü㑯ω㏑ゾ∞ミ㞩㚇ミ㢄ㄌ㞖ミ�㟍㩜‹〇�ヴ㟺╠㩜�ヘœゥエ㙡‰㑉アt

�㦣㢶㩝çêょ㧦㩞㏑ゾヴミ㞩㚇㩞㑳㓳�㓮

šⅠ�㜴�㩝1



㒀㘳㔇㢳㛕㩝㒀㜛㝹�㩝











HE�.FFECT�OF�2VABRADINE�IN�1EART�/AILURE�PATIENTS�WITH�DILATED�CARDIOMYOPATHY

R[ha�T[fch#*C_�?[h-(�T[ha�R_hdc_#*Gc�Echa.

$-�*?_j[lng_hn�i`�[l^cifias(�Rob[h�mc[h�b_[ln�^cm_[m_�bimjcn[f(Rob[h�0/,,..㩜Co\_c7.�Rob[h�

chn_al[n_^�nl[^cncih[f�bch_m_�[h^�R_mn_lh�g_^c]ch_�bimjcn[D(Rob[h�0/,,/,(Co\_c%

\mn�l[]n6�J\�d_]n�c�p_�Ob_�[cg�i`�cbcm�j[j_l�q[m�ni�chp_mnca[n_�nb_�_``_]n�i`�cp[\l[^ch_�ch�b_[lf�`[cfol_�j[fc_hfm�qcnb�^cf[n_^�

][l^cigsij[nbs�]igbch_`f�ih�nb_�mn[h^[l^�g_^c]ch_*H_nbi^m�R_�l_]locn_^�44�_fcac\f_�j[fc_hnm�f:_nq__h�H[l]b�.,-5�[h^�?nc]YgfYl�

.,.,*ff�j[nc_hnm�l_]_cp_^�g_^c][f�j_l`ilg[h]_�qcnb�cp[\l[^ch_�\[m_^�ih�nb_�aoc^_fch_�ch�bch[*$y_h_l[f�^[n[�q_l_�liff_nc_^�[`f_l�2�

gihnbm�nl_[ng_hn*M_mofnm�`n_l�`iffiq)oj�nb_�b_[ln�l[n_�ch�j[nc_hnm�^_]l_[m_^�$-,*3/�x�-2*45%�Dq[Gm+hcch�$㆞8�,*$%,,-%�Pdn�nb_�

\fii^�jl_mmol_�ch]l_[*m__f�$3*25�x�.1*-5%�gyhCa�$K8�,*,.%�qb_l_[m�nb_l_�q[m�hi�mcaccc`cl[hf�]b[ha_�ch�$fc[mfifcl

Dh�[^^cncih(nb_�f_`n�p_hnlc]of[l�_d_]ncih�`l[]ncih�ch]l_[m_^�\s�3�$Y�8,*,,$%�-�%([h^�nb_�f_`n�p_hflc]of[l�_h^�^c[mnifc]�^c[g_f_l�[h^�cb_�f_`n�

p_hnlc]of[l�msmnifc]�^c[g_n_l�q_l_�l_^o]_^�\s�/gg